Michael Lee Overview
- Company
- Shattuck Labs
- Primary Position
-
Board Member
- Primary Industry
-
Healthcare
- Active Board Seats
-
4
- Med. Deal Size
-
- Med. Valuation
-
Michael Lee General Information
Biography
Mr. Michael Lee serves as Board Member at Fate Therapeutics. Mr. Lee serves as Board Member at Shattuck Labs. He serves as Board Member at IGM Biosciences. He co-founded and served Portfolio Manager at Redmile Group.
Contact Information
Address
- 1018 West 11th Street
- Suite 100
- Austin, TX 78703
- United States
Michael Lee Board Seats (4)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| AgomAb | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Antwerp, Belgium | |
| Fate Therapeutics | Biotechnology | Publicly Held | Formerly VC-backed | San Diego, CA | |
| IGM Biosciences | Biotechnology | Publicly Held | Formerly VC-backed | Mountain View, CA | |
| Shattuck Labs | Biotechnology | Publicly Held | Formerly VC-backed | Austin, TX |
Michael Lee Lead Partner on Deals (9)
Michael Lee has been the lead partner on 9 deals. Their latest deal was with IGM Biosciences, a biotechnology company. The deal was made for on 22-Jun-2023.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| IGM Biosciences | 22-Jun-2023 | PIPE | Completed | Biotechnology | Mountain View, CA | |
| AgomAb | 13-Jul-2022 | Completed | Drug Discovery | Antwerp, Belgium | ||
| Shattuck Labs | 12-Jun-2020 | Completed | Biotechnology | Austin, TX | ||
| Fate Therapeutics | 10-Jun-2020 | Completed | Biotechnology | San Diego, CA | ||
| IGM Biosciences | 08-Jul-2019 | Completed | Biotechnology | Mountain View, CA | ||
| BioNTech | 04-Jan-2018 | Completed | Drug Discovery | Mainz, Germany | ||
| True North Therapeutics | 18-Oct-2016 | Completed | Drug Discovery | South San Francisco, CA | ||
| Jounce Therapeutics | 17-Apr-2015 | Early Stage VC (Series B) | Completed | Biotechnology | Cambridge, MA | |
| Scioderm | 18-Dec-2014 | Early Stage VC (Series B) | Completed | Pharmaceuticals | Durham, NC |
Michael Lee Network (187)
Board Members (53)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Ohad Hammer | AgomAb | Pontifax Venture Capital | Antwerp, Belgium | |
| William Rastetter Ph.D | Fate Therapeutics | Self | San Diego, CA | |
| Fate Therapeutics | Venrock | San Diego, CA | ||
| Shattuck Labs | Self | Austin, TX | ||
| IGM Biosciences | IGM Biosciences | Mountain View, CA |
Portfolio Executives (130)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Lisa Decker Ph.D | IGM Biosciences | Executive | 22-Jun-2023 | Mountain View, CA |
| John Shiver Ph.D | IGM Biosciences | Chief Strategy Officer | 22-Jun-2023 | Mountain View, CA |
| IGM Biosciences | Chief Medical Officer | 22-Jun-2023 | Mountain View, CA | |
| IGM Biosciences | Vice President of Human Resources Chief Human Resources Officer | 22-Jun-2023 | Mountain View, CA | |
| IGM Biosciences | Chief Executive Officer & Board Member | 22-Jun-2023 | Mountain View, CA |
Fund Team Members (4)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Gerard van Hamel Platerink | Redmile Group | Redmile Biopharma Investments II | San Francisco, CA |
| Robert Faulkner | Redmile Group | Redmile Biopharma Investments I | San Francisco, CA |
| Redmile Group | San Francisco, CA | ||
| Redmile Group | San Francisco, CA | ||
| Redmile Group | San Francisco, CA |
Michael Lee Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Redmile Biopharma Investments I | Redmile Group | Venture - General | Closed | 2018 | ||||
| Redmile Biopharma Investments II | Redmile Group | Venture - General | Closed | 2020 | ||||
| Redmile Private Investments II | Redmile Group | Buyout | Closed | 2017 |
Michael Lee FAQs
-
Who is Michael Lee?
Mr. Michael Lee serves as Board Member at Fate Therapeutics.
-
How much does Michael Lee typically invest?
Michael Lee's median deal size is .
-
What is Michael Lee’s main position?
Michael Lee’s primary position is Board Member.
-
How many active board seats does Michael Lee hold?
Michael Lee holds 4 board seats including AgomAb, Fate Therapeutics, IGM Biosciences, and Shattuck Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
